CROFTWELL CONSULTING LIMITED

💤Zombieactive

SC219375 · ltd · incorporated 2001-05-22

Investment thesis

Zombie company — trading but stalled; unlikely mover.

Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.

Why risky: No growth signal; thin margin for error on price.

Why now

Window steady · low confidence

Steady and stalled — no momentum either way. Needs an approach trigger.

What changed my view

Last 30 days

No material changes in the last 30 days.

Last 90 days

No snapshot from 90 days ago — start tracking from today.

Last 180 days

No snapshot from 180 days ago — start tracking from today.

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Mar 2025

Net worth

£41.6k

book net assets

Opportunity

80/100

Exceptional

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: General medical practice activities

Sector: Human health & social work

Investor take

Pursue

Asset-holding vehicle with a 72-year-old founder — textbook succession opportunity.

Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (83/100, director aged 72). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (75/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

4 officers (2 active, 4 linked, 1 with DOB)

Ownership & PSC

2 active PSC(s) of 2 total, 2 with control declared

Director network

Network not yet resolved

Filing history

59 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

80/100Exceptional

PassWatchWorth a lookStrongExceptional

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality

Active, clean filings, stable charge profile.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)

Positive net assets

Net assets £41,581

Net assets shrinking

Down £2,843 YoY

Key financials

2 years extracted from filed iXBRL accounts

Cash

—

Net Worth

£42k

↓ 6.4% YoY

Current Assets

£43k

↓ 9.4% YoY

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)

Metric	2025-03-31	2024-03-31
Total assets	£41.6k	£44.4k
Current assets	£42.8k	£47.3k
Net assets	£41.6k	£44.4k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filing

• 1 confirmation-statement

Last 90 days

filing

• 1 confirmation-statement

Last 180 days

filing

• 1 confirmation-statement

Counts from Companies House filing history.

Corporate timeline (22 events)Click to expand

2025-07-02
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2024-11-07
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2023-11-28
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2022-11-23
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2021-11-29
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2020-12-17
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2019-11-01
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2018-12-28
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2017-12-15
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2016-12-16
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2016-05-31
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2015-12-24
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2015-05-26
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2015-01-06
📄
accounts-with-accounts-type-total-exemption-small
accounts · AA
2014-06-03
📄
annual-return-company-with-made-up-date-full-list-shareholders
annual-return · AR01
2001-05-22
🏢
Company incorporated
As CROFTWELL CONSULTING LIMITED
2001-05-22
➕
RUTHERFORD, Anne appointed
secretary
2001-05-22
➕
RUTHERFORD, Daniel, Dr appointed
director
2001-05-22
➕
OSWALDS OF EDINBURGH LIMITED appointed
corporate-nominee-secretary
2001-05-22
➖
OSWALDS OF EDINBURGH LIMITED resigned
corporate-nominee-secretary
2001-05-22
➕
JORDANS (SCOTLAND) LIMITED appointed
corporate-nominee-director
2001-05-22
➖
JORDANS (SCOTLAND) LIMITED resigned
corporate-nominee-director

Owner dependency

100/100

Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS

+Sole director: Only one active director — all governance concentrated on one person.
+Long-tenure founder: Senior director has been in place 25 years — deep operational knowledge concentrated in one person.
+Founder age: Director aged approximately 72 — succession pressure is live.

Succession & seller-readiness

100/100

Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS

primaryFounder aged 70+: Senior director is approximately 72 years old. Natural succession window is now.
primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
primary20+ year tenure: Director in role 25 years. Very long tenure is a classic succession signal.
secondaryStable-but-static management: Company is 25 years old and no new directors in the last 3 years — succession not yet being planned internally.
supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners

Name	Shares	Voting rights	Nature of control	Notified
Dr Daniel Rutherford Individual · British · DOB 12/1954 · age 72	50–75%	50–75%	board control50-75% shares · 50-75% voting · board control	22/05/2016
Mrs Anne Rutherford Individual · British · DOB 04/1957 · age 69	25–50%	25–50%	25-50% shares · 25-50% voting	22/05/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · KY postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
ABBOTSFORD CARE (GLENROTHES) LIMITED→ SC370558 · est 2009	£11.35M £8.17M–£14.53M	£18.42M	—	60000	16y	81	70y
THE DAISYCHAIN NURSERY KIRKCALDY LTD.→ SC263422 · est 2004	—	—	—	5200	22y	83	78y
PITLAIR LIMITED→ SC164594 · est 1996	—	—	—	5800	30y	82	80y
R MITEVA & ASSOCIATES LIMITED→ SC379836 · est 2010	—	—	£574.1k	—	16y	82	63y
RIVENDELL CARE SERVICES LIMITED→ SC329079 · est 2007	—	—	£273.5k	—	18y	82	86y
CHARLESTOWN PHARMACY LIMITED→ SC391110 · est 2011	—	—	—	5	15y	81	64y
FIFE INTENSIVE REHABILITATION AND SUBSTANCE USE TEAM (FIRST) LIMITED→ SC298843 · est 2006 · no financials extracted	—	—	—	—	20y	81	80y
PILGRIM CARE→ SC157367 · est 1995 · no financials extracted	—	—	—	—	31y	81	83y
THE FIFE HERBAL DISPENSARY LIMITED→ SC284939 · est 2005	—	—	—	—	21y	81	80y
BANDRUM NURSING HOME LIMITED→ SC099467 · est 1986 · no financials extracted	—	—	—	—	40y	80	88y
COLORECTAL LTD.→ SC261429 · est 2004	—	—	—	100	22y	80	64y
GELANDER LTD.→ SC250851 · est 2003	—	—	—	200	23y	80	69y

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2001-05-22

Jurisdictionscotland

Primary SIC86210 — General medical practice activities

Registered office

Croftwell

Prior Muir

St Andrews

Fife

KY16 8LP

Filing status

Accounts

Next due: 2026-12-31

Last made up to: 2025-03-31

Confirmation statement

Next due: 2027-06-05

Last: 2026-05-22

Officers (2 active · 2 resigned)

RUTHERFORD, Anne→

secretary · appointed 2001-05-22

View their other companies + combined net worth →

Active

RUTHERFORD, Daniel, Dr→

director · ~72y · appointed 2001-05-22

View their other companies + combined net worth →

Active

OSWALDS OF EDINBURGH LIMITED→

corporate-nominee-secretary · appointed 2001-05-22 · resigned 2001-05-22

Resigned

JORDANS (SCOTLAND) LIMITED→

corporate-nominee-director · appointed 2001-05-22 · resigned 2001-05-22

Resigned

Click a director name to see their full track record across all companies.